[1]
|
Wang, X., Ye, T., Xue, B., et al. (2021) Mitochondrial GRIM-19 Deficiency Facilitates Gastric Cancer Metastasis through Oncogenic ROS-NRF2-HO-1 Axis via a NRF2-HO-1 Loop. Gastric Cancer, 24, 117-132.
https://doi.org/10.1007/s10120-020-01111-2
|
[2]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[3]
|
Ilic, M. and Ilic, I. (2022) Epidemiology of Stomach Cancer. World Jour-nal of Gastroenterology, 28, 1187-1203.
https://doi.org/10.3748/wjg.v28.i12.1187
|
[4]
|
曹毛毛, 陈万青. GLOBOCAN2020全球癌症统计数据解读[J]. 中国医学前沿杂志(电子版), 2021, 13(3): 63-69.
|
[5]
|
舍雅莉, 赵晓文, 李俊杰, 等. 敦煌平胃丸联合顺铂对SCG-7901胃癌荷瘤小鼠的抑瘤作用及肾毒性研究[J]. 中药药理与临床, 2021, 37(2): 13-18. https://doi.org/10.13412/j.cnki.zyyl.20210322.007
|
[6]
|
Machlowska, J., Baj, J., Sitarz, M., et al. (2020) Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences, 21, 4012.
https://doi.org/10.3390/ijms21114012
|
[7]
|
罗劲松, 何淼, 杨桄权. 胃癌的临床诊断、形成机理以及临床治疗[J]. 基因组学与应用生物学, 2021, 40(2): 936-940. https://doi.org/10.13417/j.gab.040.000936
|
[8]
|
Wang, K., Chen, Q., Shao, Y., et al. (2021) Anticancer Activities of TCM and Their Active Components against Tumor Metastasis. Biomedicine & Pharmacotherapy, 133, Article ID: 111044.
https://doi.org/10.1016/j.biopha.2020.111044
|
[9]
|
Petryszyn, P., Chapelle, N. and Matysiak-Budnik, T. (2020) Gastric Cancer: Where Are We Heading? Digestive Diseases, 38, 280-285. https://doi.org/10.1159/000506509
|
[10]
|
Smyth, E.C., Nilsson, M., Grabsch, H.I., et al. (2020) Gastric Cancer. The Lancet, 396, 635-648.
https://doi.org/10.1016/S0140-6736(20)31288-5
|
[11]
|
Li, B., Nasser, M.I., Masood, M., et al. (2020) Efficiency of Traditional Chinese Medicine Targeting the Nrf2/HO-1 Signaling Pathway. Biomedicine & Pharmacotherapy, 126, Arti-cle ID: 110074.
https://doi.org/10.1016/j.biopha.2020.110074
|
[12]
|
Wang, C., Yuan, Y., Wu, J., et al. (2019) Plin5 Deficiency Ex-acerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure by Enhancing Myocardial Fatty Acid Oxi-dation and Oxidative Stress. Free Radical Biology and Medicine, 141, 372-382. https://doi.org/10.1016/j.freeradbiomed.2019.07.006
|
[13]
|
Katsuoka, F., Otsuki, A., Takahashi, M., et al. (2019) Direct and Specific Functional Evaluation of the Nrf2 and MafG Heterodimer by Introducing a Tethered Dimer into Small Maf-Deficient Cells. Molecular and Cellular Biology, 39, e00273-19. https://doi.org/10.1128/MCB.00273-19
|
[14]
|
Silva-Palacios, A., Ostolga-Chavarría, M., Zazueta, C., et al. (2018) Nrf2: Molecular and Epigenetic Regulation during Aging. Ageing Research Reviews, 47, 31-40. https://doi.org/10.1016/j.arr.2018.06.003
|
[15]
|
Hybertson, B.M., Gao, B., Bose, S.K., et al. (2011) Oxidative Stress in Health and Disease: The Therapeutic Potential of Nrf2 Activation. Molecular Aspects of Medicine, 32, 234-246. https://doi.org/10.1016/j.mam.2011.10.006
|
[16]
|
Na, H.K. and Surh, Y.J. (2014) Oncogenic Potential of Nrf2 and Its Principal Target Protein Heme Oxygenase-1. Free Radical Biology and Medicine, 67, 353-365. https://doi.org/10.1016/j.freeradbiomed.2013.10.819
|
[17]
|
Chiang, S.K., Chen, S.E. and Chang, L.C. (2018) A Dual Role of Heme Oxygenase-1 in Cancer Cells. International Journal of Molecular Sciences, 20, 39. https://doi.org/10.3390/ijms20010039
|
[18]
|
Nitti, M., Piras, S., Marinari, U., et al. (2017) HO-1 Induction in Can-cer Progression: A Matter of Cell Adaptation. Antioxidants, 6, 29. https://doi.org/10.3390/antiox6020029
|
[19]
|
Menegon, S., Columbano, A. and Giordano, S. (2016) The Dual Roles of NRF2 in Cancer. Trends in Molecular Medicine, 22, 578-593. https://doi.org/10.1016/j.molmed.2016.05.002
|
[20]
|
Farkhondeh, T., Folgado, S.L., Pourbagher-Shahri, A.M., et al. (2020) The Therapeutic Effect of Resveratrol: Focusing on the Nrf2 Signaling Pathway. Biomedicine & Pharmacothera-py, 127, Article ID: 110234.
https://doi.org/10.1016/j.biopha.2020.110234
|
[21]
|
Sporn, M.B. and Liby, K.T. (2012) NRF2 and Cancer: The Good, the Bad and the Importance of Context. Nature Reviews Cancer, 12, 564-571. https://doi.org/10.1038/nrc3278
|
[22]
|
Deshmukh, P., Unni, S., Krishnappa, G., et al. (2017) The Keap1-Nrf2 Path-way: Promising Therapeutic Target to Counteract ROS-Mediated Damage in Cancers and Neurodegenerative Diseases. Biophysical Reviews, 9, 41-56.
https://doi.org/10.1007/s12551-016-0244-4
|
[23]
|
Deng, Y., Wu, Y., Zhao, P., et al. (2019) The Nrf2/HO-1 Axis Can Be a Prognostic Factor in Clear Cell Renal Cell Carcinoma. Cancer Management and Research, 11, 1221-1230. https://doi.org/10.2147/CMAR.S188046
|
[24]
|
Yang, Y., Wang, X., Zhang, J., et al. (2022) Abnormal Phenotype of Nrf2 Is Associated with Poor Prognosis through Hypoxic/VEGF-A-Rap1b/VEGFR2 Pathway in Gastric Cancer. Aging (Albany NY), 14, 3293-3312.
https://doi.org/10.18632/aging.204013
|
[25]
|
陈骢, 郝健淇, 彭皓宁, 等. BCL-2家族凋亡调控作用及其介导的抗肿瘤药物治疗后耐药的研究进展[J]. 中国胸心血管外科临床杂志, 2023, 30(1): 140-148.
|
[26]
|
Boise, H., Gonzblez-Garcia, M., Postema, E., et al. (1993) bcl-x, a bcl-2-Related Gene that Functions as a Dominant Regulator of Apoptotic Cell Death. Cell, 74, 597-608. https://doi.org/10.1016/0092-8674(93)90508-N
|
[27]
|
Jakovic, L.R., Mihaljevic, B.S., Jovanovic, M.D.P., et al. (2012) Prognostic Significance of Bcl-2, Tumor-Associated Macrophages, and Total Neoplastic and Inflammatory Lymph Node Involvement in Advanced Stage Classical Hodgkin’s Lymphoma. Oncology Research and Treatment, 35, 733-739. https://doi.org/10.1159/000343664
|
[28]
|
Zimta, A.A., Cenariu, D., Irimie, A., et al. (2019) The Role of Nrf2 Activity in Cancer Development and Progression. Cancers, 11, 1755. https://doi.org/10.3390/cancers11111755
|
[29]
|
Ashrafizadeh, M., Fekri, H.S., Ahmadi, Z., et al. (2020) Therapeutic and Biological Activities of Berberine: The Involvement of Nrf2 Signaling Pathway. Journal of Cellular Biochemistry, 121, 1575-1585.
https://doi.org/10.1002/jcb.29392
|
[30]
|
谢晶日, 张瑜, 张冰. 探讨Keap1/Nrf-2信号通路在胃癌发展和治疗中的作用[C]//中国中西医结合学会基础理论专业委员会. 第十四届中国中西医结合基础理论学术年会会议资料. [出版者不详], 2018: 7.
|
[31]
|
Shibuya, M. (2013) Vascular Endothelial Growth Factor and Its Receptor System: Physi-ological Functions in Angiogenesis and Pathological Roles in Various Diseases. The Journal of Biochemistry, 153, 13-19.
https://doi.org/10.1093/jb/mvs136
|
[32]
|
Goel, H.L. and Mercurio, A.M. (2013) VEGF Targets the Tumour Cell. Nature Reviews Cancer, 13, 871-882.
https://doi.org/10.1038/nrc3627
|
[33]
|
Melincovici, C.S., Bo, A.B., Mihu, C., et al. (2018) Vascular Endothelial Growth Factor (VEGF)—Key Factor in Normal and Pathological Angiogenesis. Romanian Journal of Morphology and Embryology, 59, 455-467.
|
[34]
|
Cuzziol, C.I., Castanhole-Nunes, M.M.U., Pavarino, É.C., et al. (2020) MicroRNAs as Regulators of VEGFA and NFE2L2 in Cancer. Gene, 759, Article ID: 144994. https://doi.org/10.1016/j.gene.2020.144994
|
[35]
|
Li, R., Jia, Z. and Zhu, H. (2019) Regulation of Nrf2 Signaling. The Reactive Oxygen Species (Apex), 8, 312-322.
https://doi.org/10.20455/ros.2019.865
|
[36]
|
Ma, Q. (2013) Role of Nrf2 in Oxidative Stress and Toxicity. Annual Review of Pharmacology and Toxicology, 53, 401-426. https://doi.org/10.1146/annurev-pharmtox-011112-140320
|
[37]
|
Jaramillo, M.C. and Zhang, D.D. (2013) The Emerging Role of the Nrf2-Keap1 Signaling Pathway in Cancer. Genes & Development, 27, 2179-2191. https://doi.org/10.1101/gad.225680.113
|
[38]
|
Kawasaki, Y. (2015) Clinicopathological Significance of Nuclear Factor (Erythroid-2)-Related Factor 2 (Nrf2) Expression in Gastric Cancer. BMC Cancer, 15, Article No. 5. https://doi.org/10.1186/s12885-015-1008-4
|
[39]
|
Januchowski, R., Wojtowicz, K. andrzejewska, M., et al. (2014) Expression of MDR1 and MDR3 Gene Products in Paclitaxel-, Doxorubicin- and Vincristine-Resistant Cell Lines. Bio-medicine & Pharmacotherapy, 68, 111-117.
https://doi.org/10.1016/j.biopha.2013.09.004
|
[40]
|
Jeddi, F., Soozangar, N., Sadeghi, M.R., et al. (2017) Contra-dictory Roles of Nrf2/Keap1 Signaling Pathway in Cancer Prevention/Promotion and Chemoresistance. DNA Repair, 54, 13-21. https://doi.org/10.1016/j.dnarep.2017.03.008
|
[41]
|
康意, 张静, 王晓玲, 等. Nrf2-ARE通路与肿瘤耐药的研究进展[J]. 医学综述, 2019, 25(23): 4662-4667.
|
[42]
|
Jeddi, F., Soozangar, N., Sadeghi, M.R., et al. (2018) Nrf2 Overexpression Is Associated with P-Glycoprotein Upregulation in Gastric Cancer. Biomedicine & Pharmacotherapy, 97, 286-292. https://doi.org/10.1016/j.biopha.2017.10.129
|
[43]
|
Wang, X., Campos, C.R., Peart, J.C., et al. (2014) Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers. Journal of Neuroscience, 34, 8585-8593.
https://doi.org/10.1523/JNEUROSCI.2935-13.2014
|